Human Motion Institute

back

Predicting gadolinium-enhancement status in MS patients eligible for randomized clinical trials.

Barkhof F., Held U., Petkau J., Menzler S., Simon J., Daumer M., et al: Neurology 65, p. 1447-1454

European Union Framework 7 BMBF - Federal Ministry of Education and Research BMWI - Federal Ministry of Business and Technology Deutsches Kompetenznetzwerk Multiple Sklerose Hertie Foundation University of Oxford, UK Imperial College, London, UK Bavarian Research Foundation University of Cambridge Mayo Clinic, US University of Rochester, US US National MS Society UK Multiple Sclerosis Society Hilton Foundation, US GE Healthcare European Medicines Agency European Commission
Our site uses 2 temporary technical cookies , a session cookie to navigate the site and a cookie protecting your form input from Cross Site Request Forgery.